Literature DB >> 9159311

Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature.

V S Mathur1, J L Olson, T M Darragh, T S Yen.   

Abstract

We present two case reports of renal polyomavirus infection leading to renal allograft dysfunction, review the literature of this entity, and discuss the role of specific immunosupressives. Histologically, the virus caused an interstitial infiltrate composed of plasma cells and lymphocytes, interstitial fibrosis, and tubular atrophy. Viral inclusions were seen within tubular cells on light microscopy. Electron microscopy showed viral particles of 40 to 50 nm in a characteristic paracrystalline array. Both patients had been on FK-506-based immunosuppression. In both patients, the virus appeared to clear histologically and renal function stabilized when the patients were converted to cyclosporine-based immunosuppression. Contrary to prior reports, our patients have not lost their grafts and continue to have stable, albeit reduced, graft function at 2.5 years and 4.5 years following the initial diagnosis of renal polyomavirus infection.

Entities:  

Mesh:

Year:  1997        PMID: 9159311

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  High incidence of JC viruria in JC-seropositive older individuals.

Authors:  Han Chang; Meilin Wang; Rong-Tai Tsai; Hui-Sheng Lin; Jin-Shue Huan; Wen-Chuang Wang; Deching Chang
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

Review 2.  [BK virus nephropathy after kidney transplantation].

Authors:  V Bröcker; A Schwarz; J U Becker
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 3.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

Review 4.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

5.  Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.

Authors:  Belinda T Lee; Steven Gabardi; Monica Grafals; R Michael Hofmann; Enver Akalin; Aws Aljanabi; Didier A Mandelbrot; Deborah B Adey; Eliot Heher; Pang-Yen Fan; Sarah Conte; Christine Dyer-Ward; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 8.237

6.  Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys.

Authors:  M A van Gorder; P Della Pelle; J W Henson; D H Sachs; A B Cosimi; R B Colvin
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease.

Authors:  R D Smith; J H Galla; K Skahan; P Anderson; C C Linnemann; G S Ault; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Renaud A Du Pasquier; Prabir Roy-Chaudhury; Marcelo J Kuroda; E Steve Woodle; Kamel Khalili; Igor J Koralnik
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 9.  BK virus nephritis after renal transplantation.

Authors:  Aaron Dall; Sundaram Hariharan
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

10.  Risk factors for polyoma virus nephropathy.

Authors:  Olivier Prince; Spasenija Savic; Michael Dickenmann; Jürg Steiger; Lukas Bubendorf; Michael J Mihatsch
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.